Arrowstreet Capital Portfolio holdings
AUM
$141B
This Quarter Return
+2.2%
1 Year Return
+32.28%
3 Year Return
+131.72%
5 Year Return
+249.71%
10 Year Return
+627.08%
AUM
$43.6B
AUM Growth
+$43.6B
(+4.8%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
18.28%
Holding
1,493
New
278
Increased
387
Reduced
400
Closed
399
Top Buys
| 1 |
AbbVie
ABBV
|
$581M |
| 2 |
IBM
IBM
|
$395M |
| 3 |
Toronto Dominion Bank
TD
|
$381M |
| 4 |
Boeing
BA
|
$309M |
| 5 |
Biogen
BIIB
|
$300M |
Top Sells
| 1 |
Philip Morris
PM
|
$349M |
| 2 |
TSMC
TSM
|
$324M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
$305M |
| 4 |
CVS Health
CVS
|
$304M |
| 5 |
Merck
MRK
|
$272M |
Sector Composition
| 1 | Technology | 17.47% |
| 2 | Healthcare | 17.17% |
| 3 | Financials | 16.49% |
| 4 | Consumer Discretionary | 12.16% |
| 5 | Industrials | 10.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
TSMC
TSM
$1.2T
| $376M | 0.86% | 8,589,725 -7,406,086 | -46% | -$324M |
|
27
Vertex Pharmaceuticals
VRTX
$100B
| $346M | 0.79% | 2,125,216 +921,995 | +77% | +$150M |
|
28
Rio Tinto
RIO
$102B
| $343M | 0.79% | 6,657,336 +2,165,883 | +48% | +$112M |
|
29
McDonald's
MCD
$224B
| $340M | 0.78% | 2,172,237 +1,165,500 | +116% | +$182M |
|
|
RHT
30
DELISTED
Red Hat Inc
RHT
| $334M | 0.77% | 2,235,150 +90,550 | +4% | +$13.5M |
|
31
Petrobras
PBR
$79.9B
| $320M | 0.73% | 22,618,523 +12,078,069 | +115% | +$171M |
|
|
32
Biogen
BIIB
$19.4B
| $313M | 0.72% | 1,143,854 +1,094,854 | +2,234% | +$300M |
|
33
Las Vegas Sands
LVS
$39.6B
| $301M | 0.69% | 4,190,578 +1,921,180 | +85% | +$138M |
|
34
SiriusXM
SIRI
$7.96B
| $293M | 0.67% | 47,009,589 +3,184,838 | +7% | +$19.9M |
|
35
Capital One
COF
$145B
| $290M | 0.67% | 3,026,754 -940,569 | -24% | -$90.1M |
|
36
Marsh & McLennan
MMC
$101B
| $272M | 0.62% | 3,291,819 +739,653 | +29% | +$61.1M |
|
37
Constellation Brands
STZ
$28.5B
| $269M | 0.62% | 1,179,284 -4,653 | -0.4% | -$1.06M |
|
38
HCA Healthcare
HCA
$94.5B
| $268M | 0.62% | 2,766,713 -214,242 | -7% | -$20.8M |
|
39
Visa
V
$683B
| $267M | 0.61% | 2,234,041 -758,597 | -25% | -$90.7M |
|
40
Cigna
CI
$80.3B
| $262M | 0.6% | 1,560,143 +939,830 | +152% | +$158M |
|
|
41
Philip Morris
PM
$260B
| $261M | 0.6% | 2,622,091 -3,514,467 | -57% | -$349M |
|
42
Gilead Sciences
GILD
$140B
| $239M | 0.55% | 3,175,747 +105,420 | +3% | +$7.95M |
|
43
Cognizant
CTSH
$35.3B
| $237M | 0.54% | 2,938,137 -1,484,456 | -34% | -$119M |
|
44
Best Buy
BBY
$15.6B
| $228M | 0.52% | 3,252,754 +1,131,260 | +53% | +$79.2M |
|
45
Align Technology
ALGN
$10.3B
| $227M | 0.52% | 904,234 +184,823 | +26% | +$46.4M |
|
46
AB InBev
BUD
$122B
| $227M | 0.52% | +2,063,707 | New | +$227M |
|
47
Banco Bradesco
BBD
$32.9B
| $222M | 0.51% | 18,719,955 +8,515,067 | +83% | +$101M |
|
48
US Bancorp
USB
$76B
| $220M | 0.5% | 4,348,274 +2,818,751 | +184% | +$142M |
|
|
ESRX
49
DELISTED
Express Scripts Holding Company
ESRX
| $214M | 0.49% | 3,094,266 -356,578 | -10% | -$24.6M |
|
50
Idexx Laboratories
IDXX
$51.8B
| $206M | 0.47% | 1,074,989 -179,424 | -14% | -$34.3M |
|